STAT+: Roche to launch another Elevidys trial, with eyes on European approval
STAT [Unofficial]
April 16, 2026
Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in Europe.
Discussion in the ATmosphere